Myriad Genetics Win on Gene Patent Ownership Is Appealed

Myriad Genetics Inc.’s Australian court victory recognizing its ownership of patents for genes linked to cancer risks will be appealed by a group representing cancer patients, a law firm said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.